-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Article source: Medical Rubik's Cube Info
Author: Fengqiu
On August 17, the "Letter on Invitation to Participate in the Centralized Procurement of Proprietary Chinese Patent Medicines in Provincial Cross-Regional Alliances" issued by the Hubei Provincial Medical Security Bureau was circulated on the Internet.
Judging from the catalogue list, there are 17 groups of products involved
In 2020, the country and provinces and cities respectively announced the list of key monitored drugs, which is also a key step in restricting auxiliary drugs
According to PharmaGo data, 17 groups involve a total of 376 listed products, and several group companies such as Harbin Pharmaceutical, Kunyao Group, China Resources Pharmaceutical, and Guizhou Braun have more than 6 products
The specific list of 17 product groups is as follows: